Leukemia & Lymphoma, Volume 64, Issue 4 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 64, Issue 4 (2023)

See all volumes and issues
Vol 65, 2024 Volume 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Commentaries

Article Commentary
Venetoclax and hypomethylating agent therapy for accelerated and blast phase BCR::ABL negative myeloproliferative and extramedullary disease
Zhi-Han Yeoh & Andrew Wei
Pages: 757-760
Published online: 10 Apr 2023
First Page PreviewforVenetoclax and hypomethylating agent therapy for accelerated and blast phase BCR::ABL negative myeloproliferative and extramedullary disease | Full Text | References | PDF (303.6 KB) | EPUB
  • 137 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Review
Follicular lymphoma: an update on biology and optimal therapy
Luca Fischer & Martin Dreyling
Pages: 761-775
Published online: 09 Feb 2023
AbstractforFollicular lymphoma: an update on biology and optimal therapy | Full Text | References | PDF (2 MB) | EPUB
  • 547 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Asparaginase therapy in patients with acute lymphoblastic leukemia: expert opinion on use and toxicity management
Melissa Sandley & Jonathan Angus
Pages: 776-787
Published online: 13 Feb 2023
AbstractforAsparaginase therapy in patients with acute lymphoblastic leukemia: expert opinion on use and toxicity management | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 3554 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review
The inherited genetic contribution and polygenic risk score for risk of CLL and MBL: a narrative review
Geffen Kleinstern & Susan L. Slager
Pages: 788-798
Published online: 28 Dec 2022
AbstractforThe inherited genetic contribution and polygenic risk score for risk of CLL and MBL: a narrative review | Full Text | References | PDF (2.1 MB) | EPUB
  • 1354 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review
Plasmablastic lymphoma: from genetics to treatment
Fabian Frontzek, Stephan Hailfinger & Georg Lenz
Pages: 799-807
Published online: 28 Dec 2022
AbstractforPlasmablastic lymphoma: from genetics to treatment | Full Text | References | PDF (1.1 MB) | EPUB
  • 437 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
CAR T-cells and macrophages in large B-cell lymphoma: impact on toxicity and efficacy
Ajlan Al Zaki, Dustin McCurry & Paolo Strati
Pages: 808-815
Published online: 08 Mar 2023
AbstractforCAR T-cells and macrophages in large B-cell lymphoma: impact on toxicity and efficacy | Full Text | References | PDF (1,016.5 KB) | EPUB
  • 456 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Articles

Article
Primary plasma cell leukemia in Latin America: demographic, clinical, and prognostic characteristics. A study of GELAMM group
Camila Peña, Eloísa Riva, Natalia Schutz, Aline Ramírez, Jule Vásquez, Daniel del Carpio, Cristian Seehaus, Paola Ochoa, Rosa Vengoa, Patricio Duarte, Humberto Martínez-Cordero, Yrving Figueredo, Rosa Oliday Ríos, Jhoanna Ramírez, Virginia Bove, Macarena Roa, Moisés Russo, Marcela Espinoza, Gloritza Rodriguez, Guillermina Remaggi, María Elvira Enciso, Mauricio Chandía, Dorotea Fantl & On behalf of the Grupo de Estudio Latinoamericano de Mieloma Múltiple (GELAMM)
Pages: 816-821
Published online: 25 Jan 2023
AbstractforPrimary plasma cell leukemia in Latin America: demographic, clinical, and prognostic characteristics. A study of GELAMM group | Full Text | References | PDF (819.4 KB) | EPUB
  • 379 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
A novel method to investigate drug resistance in the chronic lymphocytic leukemia (CLL) microenvironment: Analysis of CLL Cellular Environment and Response (ACCER)
Tricia Choquette, Elizabeth S. Henson, Xiaoyan Yang, James B. Johnston & Spencer B. Gibson
Pages: 822-834
Published online: 19 Feb 2023
AbstractforA novel method to investigate drug resistance in the chronic lymphocytic leukemia (CLL) microenvironment: Analysis of CLL Cellular Environment and Response (ACCER) | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 247 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Cytomegalovirus and Epstein-Barr virus infection during daratumumab treatment in patients with multiple myeloma
Shuchan Li, Gaofeng Zheng, Jingsong He, Wenjun Wu, Qingxiao Chen, Yang Yang, Donghua He, Yi Zhao, Xiaoyan Han & Zhen Cai
Pages: 835-845
Published online: 03 Feb 2023
AbstractforCytomegalovirus and Epstein-Barr virus infection during daratumumab treatment in patients with multiple myeloma | Full Text | References | PDF (1.3 MB) | EPUB
  • 1944 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
Khaled Sanber, Kevin Ye, Hua-Ling Tsai, Matthew Newman, Jonathan A. Webster, Ivana Gojo, Gabriel Ghiaur, Gabrielle T. Prince, Lukasz P. Gondek, B. Douglas Smith, Mark J. Levis, Amy E. DeZern, Alexander J. Ambinder, William B. Dalton & Tania Jain
Pages: 846-855
Published online: 06 Feb 2023
AbstractforVenetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 601 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Wilms’ tumor 1 expression combined with genetic mutations for prognostic assessment in MDS
Danqi Pan, Wenshu Zhao, Qianli Jiang, Changxin Yin, Han He, Libin Liao, Jieyu Ye & Min Dai
Pages: 856-864
Published online: 11 Mar 2023
AbstractforWilms’ tumor 1 expression combined with genetic mutations for prognostic assessment in MDS | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 142 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
A decrease in newly diagnosed patients with adult T-cell leukemia/lymphoma in Kagoshima, a highly endemic area of HTLV-1 in southwestern Japan
Satsuki Owatari, Masahito Tokunaga, Daisuke Nakamura, Kimiharu Uozumi, Yasuko Sagara, Hitomi Nakamura, Koichi Haraguchi, Nobuaki Nakano, Makoto Yoshimitsu, Yoshikiyo Ito, Atae Utsunomiya, Maki Otsuka, Shuichi Hanada, Masako Iwanaga & Kenji Ishitsuka
Pages: 865-873
Published online: 10 Feb 2023
AbstractforA decrease in newly diagnosed patients with adult T-cell leukemia/lymphoma in Kagoshima, a highly endemic area of HTLV-1 in southwestern Japan | Full Text | References | PDF (1.7 MB) | EPUB
  • 125 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemia
Matteo Passerini, Tamar Ratishvili, Jonathon M. Monroe, Zelalem Temesgen, Thomas E. Witzig, Neil E. Kay, Richard B. Kennedy & Sameer A. Parikh
Pages: 874-883
Published online: 12 Mar 2023
AbstractforFunctional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemia | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 177 Views
  • 0 CrossRef citations
  • 0Altmetric

Letters to the Editor

Small lymphocytic lymphoma in the heart twenty years after lymphoma diagnosis
Tadeusz Robak, Jarosław D. Kasprzak, Dorota Jesionek-Kupnicka, Michał Soin & Paweł Robak
Pages: 884-888
Published online: 22 Feb 2023
First Page PreviewforSmall lymphocytic lymphoma in the heart twenty years after lymphoma diagnosis | Full Text | References | PDF (1.8 MB) | EPUB
  • 226 Views
  • 0 CrossRef citations
  • 0Altmetric
Prognostic models predicting overall survival of chronic lymphocytic leukemia (CLL) patients treated with ibrutinib-based therapies: a systematic review and meta-analysis
Stefano Molica & Diana Giannarelli
Pages: 889-892
Published online: 27 Feb 2023
First Page PreviewforPrognostic models predicting overall survival of chronic lymphocytic leukemia (CLL) patients treated with ibrutinib-based therapies: a systematic review and meta-analysis | Full Text | References | PDF (898.9 KB) | EPUB | Supplemental
  • 185 Views
  • 0 CrossRef citations
  • 0Altmetric
Palpable spleen size is differently prognostic in primary and secondary myelofibrosis
Marko Lucijanic, Ivan Krecak, Ena Soric, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic & Rajko Kusec
Pages: 893-896
Published online: 17 Feb 2023
First Page PreviewforPalpable spleen size is differently prognostic in primary and secondary myelofibrosis | Full Text | References | PDF (966.6 KB) | EPUB | Supplemental
  • 135 Views
  • 0 CrossRef citations
  • 0Altmetric
Report of four acute myeloid leukemia patients with sustained complete remission with less frequent administration of decitabine and venetoclax
Ahmed Aribi, Amandeep Salhotra, Brian Ball, Anthony Stein, Guido Marcucci & Vinod Pullarkat
Pages: 897-899
Published online: 27 Feb 2023
First Page PreviewforReport of four acute myeloid leukemia patients with sustained complete remission with less frequent administration of decitabine and venetoclax | Full Text | References | PDF (412.5 KB) | EPUB
  • 144 Views
  • 0 CrossRef citations
  • 0Altmetric
Effect of anti-CD38 monoclonal antibodies on hepatitis C virus replication in chronically infected patients with multiple myeloma: a prospective series
Chia-Yu Chiu, Khalis Mustafayev, Hans C. Lee, Elisabet E. Manasanch, Eduardo Yepez Guevara & Harrys A. Torres
Pages: 900-903
Published online: 08 Mar 2023
First Page PreviewforEffect of anti-CD38 monoclonal antibodies on hepatitis C virus replication in chronically infected patients with multiple myeloma: a prospective series | Full Text | References | PDF (680.2 KB) | EPUB
  • 179 Views
  • 0 CrossRef citations
  • 0Altmetric
Hepatic Veno-occlusive disease (VOD) in multiple myeloma patient receiving Belantamab Mafodotin
Ilias Pessach, Georgia Argyrakopoulou, Fotios Petropoulos, Irene Rapti, Fotios Danglis, Enkeleida Trajce & Eleni Chandrinou
Pages: 904-906
Published online: 15 Feb 2023
First Page PreviewforHepatic Veno-occlusive disease (VOD) in multiple myeloma patient receiving Belantamab Mafodotin | Full Text | References | PDF (486.7 KB) | EPUB
  • 203 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles